| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 260.459.756 $ | +72.656.169 $ | +29,3 % | 10 | 171.132.441 $ | +21.830.466 $ | +31,6 % | 7 | 173.458.514 $ | +7.488.159 $ | +18,1 % | 8 | ||||
| Aktis Oncology, Inc. | AKTS | → 0 | Stark | 56.556.516 $ | +56.556.516 $ | 1 | |||||||||
| Nuveen Churchill Direct Lending Corp. | NCDL | → 0 | Neutral | 27.266.923 $ | -1.329.048 $ | -4,6 % | 1 | 28.595.971 $ | -14.067.461 $ | -33,0 % | 1 | 42.663.432 $ | -22.736.931 $ | -34,8 % | 1 |
| Larimar Therapeutics, Inc. | LRMR | → 0 | Neutral | 33.953.064 $ | +7.954.805 $ | +30,6 % | 1 | 25.998.259 $ | +7.092.940 $ | +37,5 % | 1 | 18.905.319 $ | +4.663.283 $ | +32,7 % | 1 |
| enGene Therapeutics Inc. | ENGN | → 0 | Schwach | 30.075.364 $ | -273.897 $ | -0,9 % | 1 | 30.349.261 $ | +7.959.797 $ | +35,6 % | 1 | 22.389.464 $ | +8.819.158 $ | +65,0 % | 1 |
| Cullinan Therapeutics, Inc. | CGEM | → 0 | Neutral | 27.137.746 $ | +2.805.186 $ | +11,5 % | 1 | 24.332.560 $ | +9.442.496 $ | +63,4 % | 1 | 14.890.064 $ | -3.076.305 $ | -17,1 % | 1 |
| Blue Owl Capital Corp | OBDC | → 0 | Stark | 22.618.474 $ | -3.497.070 $ | -13,4 % | 1 | 26.115.544 $ | +0 $ | +0,0 % | 1 | 26.115.544 $ | -3.210.760 $ | -10,9 % | 1 |
| MapLight Therapeutics, Inc. | MPLT | → 0 | Schwach | 20.450.537 $ | +14.705.763 $ | +256,0 % | 1 | ||||||||
| Compass Therapeutics, Inc. | CMPX | → 0 | Stark | 16.060.667 $ | -2.554.572 $ | -13,7 % | 1 | 18.615.239 $ | +9.544.901 $ | +105,2 % | 1 | ||||
| EverCommerce Inc. | EVCM | → 0 | Neutral | 18.274.670 $ | +1.034.415 $ | +6,0 % | 1 | ||||||||
| Holley Inc. | HLLY | → 0 | Stark | 13.007.246 $ | -4.118.361 $ | -24,0 % | 1 | 17.125.607 $ | +1.857.793 $ | +12,2 % | 1 | 15.267.814 $ | +7.043.092 $ | +85,6 % | 1 |
| Roivant Sciences Ltd. | ROIV | → 0 | Schwach | 14.952.207 $ | +14.952.207 $ | 1 | |||||||||
| Context Therapeutics Inc. | CNTX | → 0 | Neutral | 13.333.219 $ | +2.406.847 $ | +22,0 % | 1 | ||||||||
| 260.459.756 $ | +72.656.169 $ | +29,3 % | 10 | 171.132.441 $ | +21.830.466 $ | +31,6 % | 7 | 173.458.514 $ | +7.488.159 $ | +18,1 % | 8 | ||||